Comprehensive Dissection of PDGF-PDGFR Signaling Pathways in PDGFR Genetically Defined Cells

被引:98
作者
Wu, Erxi [1 ,2 ]
Palmer, Nathan [3 ]
Tian, Ze [1 ]
Moseman, Annie P. [1 ]
Galdzicki, Michal [1 ]
Wang, Xuetao [1 ]
Berger, Bonnie [3 ,4 ]
Zhang, Hongbing [5 ,6 ]
Kohane, Isaac S. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Childrens Hosp Boston, Informat Program, Boston, MA 02115 USA
[2] Harvard Univ, Div Hlth Sci & Technol, MIT, Cambridge, MA 02138 USA
[3] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA
[4] MIT, Dept Math, Cambridge, MA 02139 USA
[5] Tsinghua Univ, Peking Union Med Coll, Beijing, Peoples R China
[6] Chinese Acad Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Dept Physiol & Pathophysiol, Beijing 100864, Peoples R China
来源
PLOS ONE | 2008年 / 3卷 / 11期
基金
美国国家卫生研究院;
关键词
D O I
10.1371/journal.pone.0003794
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Despite the growing understanding of PDGF signaling, studies of PDGF function have encountered two major obstacles: the functional redundancy of PDGFR alpha and PDGFR beta in vitro and their distinct roles in vivo. Here we used wild-type mouse embryonic fibroblasts (MEF), MEF null for either PDGFR alpha, beta, or both to dissect PDGF-PDGFR signaling pathways. These four PDGFR genetically defined cells provided us a platform to study the relative contributions of the pathways triggered by the two PDGF receptors. They were treated with PDGF-BB and analyzed for differential gene expression, in vitro proliferation and differential response to pharmacological effects. No genes were differentially expressed in the double null cells, suggesting minimal receptor-independent signaling. Protean differentiation and proliferation pathways are commonly regulated by PDGFR alpha, PDGFR beta and PDGFR alpha/beta while each receptor is also responsible for regulating unique signaling pathways. Furthermore, some signaling is solely modulated through heterodimeric PDGFR alpha/beta.
引用
收藏
页数:15
相关论文
共 39 条
  • [1] Andrews A, 1999, INVEST OPHTH VIS SCI, V40, P2683
  • [2] Gene expression-based screening for inhibitors of PDGFR signaling
    Antipova, Alena A.
    Stockwell, Brent R.
    Golub, Todd R.
    [J]. GENOME BIOLOGY, 2008, 9 (03)
  • [3] Gene Ontology: tool for the unification of biology
    Ashburner, M
    Ball, CA
    Blake, JA
    Botstein, D
    Butler, H
    Cherry, JM
    Davis, AP
    Dolinski, K
    Dwight, SS
    Eppig, JT
    Harris, MA
    Hill, DP
    Issel-Tarver, L
    Kasarskis, A
    Lewis, S
    Matese, JC
    Richardson, JE
    Ringwald, M
    Rubin, GM
    Sherlock, G
    [J]. NATURE GENETICS, 2000, 25 (01) : 25 - 29
  • [4] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [5] CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins
    Carroll, M
    OhnoJones, S
    Tamura, S
    Buchdunger, E
    Zimmermann, J
    Lydon, NB
    Gilliland, DG
    Druker, BJ
    [J]. BLOOD, 1997, 90 (12) : 4947 - 4952
  • [6] ISOLATION AND CHARACTERIZATION OF A NOVEL CDNA FROM HL-60 CELLS TREATED WITH 1,25-DIHYDROXYVITAMIN D-3
    CHEN, KS
    DELUCA, HF
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1994, 1219 (01): : 26 - 32
  • [7] Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis
    Chen, WSV
    Delrow, J
    Corrin, PD
    Frazier, JP
    Soriano, P
    [J]. NATURE GENETICS, 2004, 36 (03) : 304 - 312
  • [8] CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023
  • [9] Perturbed IFN-γ-jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models:: Synergistic effects of rapamycin-IFN-γ treatment
    El-Hashemite, N
    Zhang, HB
    Walker, V
    Hoffmeister, KM
    Kwiatkowski, DJ
    [J]. CANCER RESEARCH, 2004, 64 (10) : 3436 - 3443
  • [10] VDUP1 upregulated by TGF-β1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression
    Han, SH
    Jeon, JH
    Ju, HR
    Jung, U
    Kim, KY
    Sook, H
    Yoo, HS
    Lee, YH
    Song, KS
    Hwang, HM
    Na, YS
    Yang, Y
    Lee, KN
    Choi, I
    [J]. ONCOGENE, 2003, 22 (26) : 4035 - 4046